Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Issuance and Control of Analytical Raw Data Sheets – V 2.0

Posted on By

Analytical Method Development: SOP for Issuance and Control of Analytical Raw Data Sheets – V 2.0

Standard Operating Procedure for Issuance and Control of Analytical Raw Data Sheets


Department Analytical Method Development
SOP No. SOP/AMD/394/2025
Supersedes SOP/AMD/394/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

To establish a systematic procedure for the issuance and control of analytical raw data sheets used in Analytical Method Development (AMD) activities such as method development,

validation, transfer, and routine analysis. This ensures accuracy, traceability, and regulatory compliance.

2. Scope

This SOP is applicable to all AMD personnel and QA personnel involved in the issuance, use, retrieval, and control of raw data sheets in the laboratory.

3. Responsibilities

  • Analyst: Requests and uses data sheets appropriately, fills entries legibly, and submits them post-use for review.
  • AMD Documentation Officer: Maintains logbooks, issues sheets with unique serial numbers, and archives used forms.
  • QA Reviewer: Verifies correct usage and reviews completed raw data for integrity and completeness.
See also  Analytical Method Development: SOP for Estimating Detection Limit Using Slope and SD Method - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring adherence to this SOP, and for safeguarding the integrity and traceability of raw analytical data sheets throughout their lifecycle.

5. Procedure

5.1 Format and Structure of Raw Data Sheets

  1. Raw data sheets must be:
    • Pre-approved by QA
    • Assigned with unique serial numbers
    • Printed on official company letterhead or preformatted templates
  2. Each sheet shall include:
    • Title and purpose
    • Reference SOP or protocol number
    • Section for date, analyst name, signature, and observations

5.2 Issuance of Raw Data Sheets

  1. The AMD Documentation Officer maintains an issuance register (Annexure-1).
  2. Sheets are issued only upon written/email request by the analyst with approval from Section Head.
  3. Details such as SOP number, project name, analyst name, and number of sheets are recorded in the issuance register.
See also  Analytical Method Development: SOP for Conducting Inter-Laboratory Analytical Method Comparability - V 2.0

5.3 Usage Guidelines

  1. Analysts must:
    • Fill entries in indelible ink
    • Correct errors by single-line strike-through with initials and date
    • Complete all fields; “NA” should be mentioned where not applicable
  2. Each page must be numbered (e.g., Page 1 of 5) and signed by the analyst at the bottom.

5.4 Post-Use Handling and Review

  1. Used sheets are submitted to AMD Reviewer for review.
  2. QA performs a secondary check for:
    • Legibility and completeness
    • Consistency with instrument records
    • Adherence to ALCOA+ principles
  3. Reviewed sheets are archived in the project-specific folder or validation dossier.

5.5 Control and Retention

  1. All issued sheets (used or unused) are returned to Documentation Officer within 15 days.
  2. Obsolete or damaged sheets are cancelled by marking “VOID” across the sheet and retained for record.
  3. All records must be retained for a minimum of 5 years or as per regulatory/QA policy.

6. Abbreviations

  • QA: Quality Assurance
  • AMD: Analytical Method Development
  • SOP: Standard Operating Procedure
  • ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate
See also  Analytical Method Development: SOP for Residual Solvent Detection in Granules - V 2.0

7. Documents

  1. Issuance Register – Annexure-1
  2. Void Sheet Log – Annexure-2

8. References

  • ICH Q9 – Quality Risk Management
  • 21 CFR Part 211 – GMP for Finished Pharmaceuticals
  • MHRA GxP Data Integrity Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Neha Sinha Abhinav Desai Dr. Harshita Goyal
Designation AMD Analyst QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Issuance Register

Issuance ID Project Analyst No. of Sheets Issue Date Return Date Remarks
IS/AMD/394/01 AMV-25 Neha Sinha 10 01/06/2025 10/06/2025 All returned

Annexure-2: Void Sheet Log

Sheet ID Void Date Reason Cancelled By
RS/AMD/394/07 02/06/2025 Damaged during handling QA

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Added Annexure formats and clarified issuance conditions Annual SOP Review Dr. Harshita Goyal
10/08/2022 1.0 Initial issue New procedure implementation QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Documentation Review Before Report Finalization – V 2.0
Next Post: Analytical Method Development: SOP for Qualification and Verification of Weighing Balances – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version